Jump in Testing After Jolie | GenomeWeb

Actress and director Angelina Jolie's disclosure in 2013 in a New York Times op-ed that she underwent a preventive double mastectomy after learning she carried a BRCA1 gene mutation increasing her risk of breast and ovarian spurred many women to also get tested, according to an AARP Public Policy Institute report.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.